AndreaElisabethWahner HendricksonMD

PubMed

• 5 citations
  A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovari...
  Julia Manzo, Shannon Puhalla, Shalu Pahuja, Fei Ding, Yan Lin, Leonard Appleman, Hussein Tawbi, Ronald Stoller, James J Lee, Brenda Diergaarde, Brian F Kiesel, Jing Yu...> ;Cancer Chemotherapy and Pharmacology. 2022 May 1
• CHFR and Paclitaxel Sensitivity of Ovarian Cancer.
  Andrea E Wahner Hendrickson, Daniel W Visscher, Xiaonan Hou, Krista M Goergen, Hunter J Atkinson, Thomas G Beito, Vivian Negron, Wilma L Lingle, Amy K Bruzek, Rachel M...> ;Cancers. 2021 Nov 30
• 1 citations
  Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study.
  Nefertiti C. duPont, Danielle Enserro, Mark F. Brady, Katherine M. Moxley, Joan L. Walker, Casey Cosgrove, Kristin Bixel, Krishnansu S. Tewari, Premal H. Thaker, Andre...> ;Gynecologic Oncology. 2021 Nov 29
• 3 citations
  Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed ...
  Gottfried E. Konecny, A.E. Wahner Hendrickson, T.M. Davidson, Boris Winterhoff, Sisi Ma, Sven Mahner, Jalid Sehouli, Peter A. Fasching, G. Feisel-Schwickardi, M. Poelc...> ;Gynecologic Oncology. 2021 Oct 9
• 27 citations
  A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
  Panagiotis A. Konstantinopoulos, Alexandre André B.A. da Costa, Doga Gulhan, Elizabeth K. Lee, Su Chun Cheng, Andrea E. Wahner Hendrickson, Bose Kochupurakkal, David L...> ;Nature Communications. 2021 Sep 22
• 4 citations
  PARP inhibitor maintenance for primary ovarian cancer - A missed opportunity for precision medicine.
  Stephanie L. Wethington, Andrea E. Wahner-Hendrickson, Elizabeth M. Swisher, Scott H. Kaufmann, Beth Y. Karlan, Amanda N. Fader, Sean C. Dowdy> ;Gynecologic Oncology. 2021 Aug 11
• 16 citations
  Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance
  Rachel M. Hurley, Cordelia D. McGehee, Ksenija Nesic, Cristina Correia, Taylor M. Weiskittel, Rebecca L. Kelly, Annapoorna Venkatachalam, Xiaonan Hou, Nicholas M. Path...> ;NAR Cancer. 2021 Jul 2
• 8 citations
  Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization.
  Upasana Ray, Debarshi Roy, Ling Jin, Prabhu Thirusangu, Julie Staub, Yinan Xiao, Eleftheria Kalogera, Andrea E. Wahner Hendrickson, Grace D. Cullen, Krista M. Goergen,...> ;Journal of Experimental & Clinical Cancer Research. 2021 Jun 3
• 97 citations
  Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
  Elizabeth M. Swisher, Tanya T. Kwan, Amit M. Oza, Anna V. Tinker, Isabelle Ray-Coquard, Ana Oaknin, Robert L. Coleman, Carol Aghajanian, Gottfried E. Konecny, David M....> ;Nature Communications. 2021 May 3
• 8 citations
  Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting.
  Ann L. Oberg, Ethan P. Heinzen, Xiaonan Hou, Mariam M. Al Hilli, Rachel M. Hurley, Andrea E. Wahner Hendrickson, Krista M. Goergen, Melissa C. Larson, Marc A. Becker, ...> ;Scientific Reports. 2021 Apr 13
• 98 citations
  Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial.
  Stephanie Lheureux, Mihaela C. Cristea, Jeff Bruce, Swati Garg, Michael Cabanero, Gina Mantia-Smaldone, Alexander B. Olawaiye, Susan Ellard, Johanne I Weberpals, Andre...> ;Lancet. 2021 Jan 23
• An unusual case of aggressive malignant spread of epithelioid hemangioendothelioma.
  Ashley Hickman, Evandro D. Bezerra, Anja C. Roden, Matthew T. Houdek, Jonathan D. Barlow, Steven I. Robinson, Andrea E. Wahner Hendrickson> ;Rare Tumors. 2021 Apr 20
• 44 citations
  Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.
  Matthew S. Block, Allan B. Dietz, Michael P. Gustafson, Kimberly R. Kalli, Courtney L. Erskine, Bahaaeldin Youssef, Geraldine V. Vijay, Jacob B. Allred, Kevin D. Pavel...> ;Nature Communications. 2020 Oct 14
• 31 citations
  Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers
  Gerardo Colon-Otero, Valentina Zanfagnin, Xiaonan Hou, Nathan R. Foster, Erik Asmus, Andrea E. Wahner Hendrickson, Aminah Jatoi, Matthew S. Block, Carrie L. Langstraat...> ;ESMO Open. 2020 Oct 1
• 6 citations
  Parental health in fellowship trainees: Fellows' satisfaction with current policies and interest in innovation.
  Ariela L. Marshall, Virginia Dines, Andrea E. Wahner Hendrickson, Rahma Warsame, Gita Thanarajasingam, Carrie A. Thompson, Tanya M. Petterson, Alexandra P. Wolanskyj-S...> ;Women's Health. 2020 Sep 29
• 109 citations
  Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.
  Panagiotis A. Konstantinopoulos, Su Chun Cheng, Andrea E. Wahner Hendrickson, Richard T. Penson, Susan Schumer, L. Austin Doyle, Elizabeth K. Lee, Elise C. Kohn, Linda...> ;The Lancet. Oncology. 2020 Jun 15
• Current and Future Directions for PARP Inhibition.
  Megan Grudem, Andrea E. Wahner Hendrickson> ;Journal of the Advanced Practitioner in Oncology. 2020 Apr 1
• 1 citations
  Loratadine for Paclitaxel-Induced Myalgias and Arthralgias.
  Caleb J. Smith, Andrea E. Wahner Hendrickson, Megan Grudem, Carolyn Klampe, Erin Deering, Aminah Jatoi> ;The American Journal of Hospice & Palliative Care. 2020 Mar 1
• 29 citations
  BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents.
  Arun Kanakkanthara, Kiran Kurmi, Thomas L. Ekstrom, Xiaonan Hou, Emma R. Purfeerst, Ethan P. Heinzen, Cristina Correia, Catherine J. Huntoon, Daniel R. O'Brien, Andrea...> ;Cancer Research. 2019 Dec 1
• Clinical Pearls in Oncology 2019.
  Andrea E. Wahner-Hendrickson, John B. Bundrick> ;Disease-a-Month. 2019 Jun 22
• 240 citations
  Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.
  Shaveta Vinayak, Sara M. Tolaney, Lee S. Schwartzberg, Monica M. Mita, Georgia A. McCann, Antoinette R. Tan, Andrea E. Wahner-Hendrickson, Andres Forero, Carey K. Ande...> ;JAMA Oncology. 2019 Jun 13
• 287 citations
  Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
  Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller, David Miller, N.G. Cloven, Gini F. Fleming, Andrea E. Wahner Hendrickson, Masoud Azodi, Paul DiSilvestro,...> ;The Lancet. Oncology. 2019 May 1
• 52 citations
  53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer
  Rachel M. Hurley, Andrea E. Wahner Hendrickson, Daniel W. Visscher, Peter Ansell, Maria I. Harrell, Jill M. Wagner, Vivian Negron, Krista M. Goergen, Matthew J. Maurer...> ;Gynecologic Oncology. 2019 Apr 1
• 3 citations
  Can Poly (ADP-Ribose) Polymerase Inhibitors Palliate Paclitaxel-Induced Peripheral Neuropathy in Patients With Cancer?
  Ryan A. Balko, Andrea E. Wahner Hendrickson, Megan Grudem, Carolyn Klampe, Aminah Jatoi> ;The American Journal of Hospice & Palliative Care. 2019 Jan 1
• 7 citations
  Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively ...
  Jason D. Doles, Kelly A. Hogan, Jennifer M O'Connor, Andrea E. Wahner Hendrickson, Olivia Huston, Aminah Jatoi> ;Journal of Palliative Medicine. 2018 Sep 1
• Join now to see all

Journal Articles

• Oncologic emergencies  
  Behl D, Hendrickson AW, Moynihan TJ, Crit Care Clin, 1/1/2010
• Insulin Receptor A and IGF-1R in AML  
  Wahner Hendrickson A, Haluska P, Erlichman C, Gottardis M, Karp JE, Carboni JM Kaufmanm SH, Cancer Res, 1/1/2010
• Insulin Receptor A and IGF-IR in AML-Response  
  Wahner-Hendrickson AE, Haluska P, Erlichman C, Gottardis M, Carboni JE, Karp JE, Kaufmann SH, Cancer Res, 1/1/2010
• Anticancer therapy: boosting the bang of Bim  
  Hendrickson AW, Meng XW, Kaufmann SH, J Clin Invest, 1/1/2008
• Porcine endothelial cells and iliac arteries transduced with AdenoIL-4 are intrinsically protected, through Akt activation, against immediate injury caused by human co...  
  Black SM, Grehan JF, Rivard AL, Benson BA, Wahner AE, Koch AE, Levay-Young BK, Dalmasso AP, J Immunol, 1/15/2006
• Progression of chronic myeloid leukemia to blast crisis during treatment with imatinib mesylate  
  Xu Y, Wahner AE, Nguyen PL, Arch Pathol Lab Med, 1/1/2004
• Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo  
  Wallace PK, Kaufman PA, Lewis LD, Keler T, Givan AL, Fisher JL, Waugh MG, Wahner AE, Guyre PM, Fanger MW, Ernstoff MS, J Immunol Methods, 1/1/2001
• Human monocytes express CD163, which is upregulated by IL-10 and identical to p155  
  Sulahian TH, Hogger P, Wahner AE, Wardwell K, Goulding NJ, Sorg C, Droste A, Stehling M, Wallace PK, Morganelli PM, Guyre PM, Cytokine, 1/1/2000
• The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis  
  Wagner UG, Kurtin PJ, Wahner A, Brackertz M, Berry DJ, Goronzy JJ, Weyand CM, J Immunol, 1/1/1998
• Join now to see all

Books/Book Chapters

• Mayo Clinic Internal Medicine Board Review 
  Chapter: Cervical, Endometrial, Ovarian Cancers. 
  Wahner Hendrickson AEEdition 11th,2014
• Innovative Leukemia and Lymphoma Therapy 
  Chapter: mTOR targeting agents for the treatment of lymphoma and leukemia. 
  Page 525 - 538Wahner Hendrickson AE, Witzig TE, Kaufmann SHEditors: Kaspers GJL, et al.Informa Healthcare, New York2008

Abstracts/Posters

• The role of CHFR Expression in Ovarian Cancer and Response to Therapy.
  Wahner Hendrickson A, Visccher D, Goergen K, Negron V, Lingle W, Oberg A, Kalli K, Hartmann L, Maurer M, Kaufmann S, Journal of Clinical Oncology, 1/1/2013
• Dual inhibition of mTORC1/mTORC2 induces apoptosis of mantle cell lymphoma by preventing Rictor mediated AKT(S413) phosphorylation by potentiating AKT2 PHLPP1 associat...
  Gupta M, Wahner Hendrickson A, Han JJ, Stenson M, Wellik L, Barr S, Kaufmann SH, Witzig TE, Blood, 1/19/2010
• OSI 027, a Dual TORC1/TORC2 inhibitor, induces bim and puma mediated apoptosis in lymphoid malignancy.
  Wahner Hendrickson AE, Gupta M, Yun S, Shing JC, Schneider PA, Peterson KL, Karp JE, Barr S, Witzig TE, Kautmann SH, Blood, 1/19/2010
• Apoptotic and Anti-Proliferative Effects of the Daul Insulin-Like Growth Factor-1 (IGF-1R)/Insulin Receptor Inhibitor, BMS 536924, in Acute Myelogenous Leukemia.
  Wahner HA, Karp JE, Attar RM, Smith DB, Wittman M, Gottardis M, Haluska P, Kaufmann SH, Proceedings of the American Association for Cancer Research, 1/1/2007
• Apoptotic and Anti-Proliferative Effects of the Dual Insulin-Like Growth Factor-1/Insulin Receptor Inhibitor, BMS 536924 in Acute Myelogenous Leukemia.
  Andrea E. Wahner Hendrickson, MD, American Association for Cancer Research, Los Angeles, CA, 1/1/2007
• IL-4 and IL-13 Gene Transfer in Porcine Endothlia Cells Induce Cytokine Protection and Protection from Apoptosis and Human Complement.
  Wahner A, Grehan J, Benson A, Koch B, Levay-Young B, Dalmasso A, Minnesota Medicine, 1/1/2004
• Progression of Chronic Myeloid Leukemia from Chronic Phase to Blast Crisis During Treatment with Imatinib Mesylate: A Report of Three Cases.
  Xu Y, Wahner AE, Nguyen PL, Modern Pathology, 1/1/2004
• IL-4 and IL-13 Gene Transfer in Porcine Endothelial Cells Induce Cytokine Production and Protection from Apoptosis and Human Complement.
  Andrea E. Wahner Hendrickson, MD, American College of Physicians Annual Session, 1/1/2004
• IL-4 and IL-13 induce gene protection of porcine endothelial cells from complement medicated killing through activation of the Pl3 kinase/AKT pathway.
  Grehan J, Wahner A, Benson A, Koch B, Levay-Young B, Dalmasso A, Xenotransplantation, 1/1/2003
• Join now to see all

Lectures

• Clinical Pearls: Infectious Diseases and Oncology 
  2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019
• "Brief Overview of Gynecologic Oncology" 
  Rochester, MN, 2013-2014 - 1/1/2015
• "Gynecologic Malignancies" 
  Lima, Peru - 1/1/2014
• "Insulin Receptor Isoform Expression in Ovarian Cancer in African American Women" 
  Tampa, FL - 1/1/2014
• "International Collaborations to Advance Treatments of Ovarian Cancer" 
  1/1/2014
• "Chemotherapy for Ovarian Cancer" 
  1/1/2013
• "Oncology Fellows Core Curriculum: Fertility Preservation in Patients with Cancer" 
  1/1/2013
• "Internal Medicine Residency Program Core Curriculum Series: Overview of Gynecologic Malignancies" 
  1/1/2013
• "Gynecologic Oncology Update for the Generalist" 
  Kauai, HI - 1/1/2013
• The role of CHFR expression in ovarian cancer and response to therapy. 
  Chicago, IL - 1/1/2013
• "Updates in Gynecologic Oncology" 
  1/1/2012
• The mTOR Pathway in Cancer 
  1/1/2012
• "Internal Medicine Core Curriculum Series: Gynecologic Malignancies" 
  1/1/2011
• "Fertility Preservation Counseling Patterns Among Hematology Oncology Health Care Providers" 
  1/1/2010
• Small Group Leader: "Chemotherapeutic Agents Used in AML" 
  1/1/2010
• "The IGF/IGF1R Pathway in Cancer" 
  1/1/2010
• "Oncology Fellows Core Curriculum: Oncologic Emergencies" 
  1/1/2010
• OSI-027, a Dual TORC1/TORC2 Inhibitor, Induces Bim-and Puma-Mediated Apoptosis in Lymphoid Malignancy. 
  Orlando, FL - 1/1/2010
• Dual Inhibition of mTORC1/mTORC2 Induces Apoptosis of Mantle Cell Lymphoma by Preventing Rictor Mediated AKT Phosphorylation by Potentiating AKT2-PJLPP1 Association. 
  Orlando, FL - 1/1/2010
• Fournier's Gangrene: A Classic Case of an Uncommon Diagnosis. 
  Minneapolis, MN - 1/1/2006
• "T Cell Lymphoma Masquerading as a Flare of Multiple Sclerosis" 
  1/1/2005
• Progression of CML from Chronic Phase to Blast Crisis During Treatment with Imatnib Mesylate: A Report of Three Cases. 
  Vancouver, British Columbia, Canada - 1/1/2004
• "IL-4 and IL-13 Gene Transfer in Procine Endothelial Cells Induce Cytokine Production and Protection from Apoptosis and Human Complement." 
  Glasgow, England - 1/1/2003
• IL-4 and IL-13 Gene Transfer in Porcine Endothelial Cells Induce Cytokine Production and Protection from Apoptosis and Human Complement. 
  Minneapolis, MN - 1/1/2003
• Join now to see all